These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21290501)

  • 1. Direct monitoring of the inhibition of protein-protein interactions in cells by translocation of PKCδ fusion proteins.
    Lee KB; Hwang JM; Choi IS; Rho J; Choi JS; Kim GH; Kim SI; Kim S; Lee ZW
    Angew Chem Int Ed Engl; 2011 Feb; 50(6):1314-7. PubMed ID: 21290501
    [No Abstract]   [Full Text] [Related]  

  • 2. Visualization and targeted disruption of protein interactions in living cells.
    Herce HD; Deng W; Helma J; Leonhardt H; Cardoso MC
    Nat Commun; 2013; 4():2660. PubMed ID: 24154492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal modifications regulate MDM2 dissociation and nuclear export of p53.
    Carter S; Bischof O; Dejean A; Vousden KH
    Nat Cell Biol; 2007 Apr; 9(4):428-35. PubMed ID: 17369817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Chemically Inducible Helper Module for Detecting Protein-Protein Interactions with Tunable Sensitivity Based on KIPPIS.
    Kashima D; Kawade R; Nagamune T; Kawahara M
    Anal Chem; 2017 May; 89(9):4824-4830. PubMed ID: 28382822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of protein-fragment complementation assay using purified firefly luciferase fragments.
    Ohmuro-Matsuyama Y; Chung CI; Ueda H
    BMC Biotechnol; 2013 Mar; 13():31. PubMed ID: 23536995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fluorescent probe for imaging p53-MDM2 protein-protein interaction.
    Liu Z; Miao Z; Li J; Fang K; Zhuang C; Du L; Sheng C; Li M
    Chem Biol Drug Des; 2015 Apr; 85(4):411-7. PubMed ID: 25226874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile analysis of protein-protein interactions in living cells by enriched visualization of the p-body.
    Choi M; Baek J; Han SB; Cho S
    BMB Rep; 2018 Oct; 51(10):526-531. PubMed ID: 29898808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
    Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
    Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein phosphatase 1 nuclear targeting subunit is a hypoxia inducible gene: its role in post-translational modification of p53 and MDM2.
    Lee SJ; Lim CJ; Min JK; Lee JK; Kim YM; Lee JY; Won MH; Kwon YG
    Cell Death Differ; 2007 Jun; 14(6):1106-16. PubMed ID: 17318220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A facile method to screen inhibitors of protein-protein interactions including MDM2-p53 displayed on T7 phage.
    Ishi K; Sugawara F
    Biochem Pharmacol; 2008 May; 75(9):1743-50. PubMed ID: 18384755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells.
    Geng QQ; Dong DF; Chen NZ; Wu YY; Li EX; Wang J; Wang SM
    Int J Oncol; 2013 Dec; 43(6):1935-42. PubMed ID: 24126697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-cell covalent labeling of reactive His-tag fused proteins.
    Uchinomiya S; Nonaka H; Wakayama S; Ojida A; Hamachi I
    Chem Commun (Camb); 2013 Jun; 49(44):5022-4. PubMed ID: 23612601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ret finger protein 2 enhances ionizing radiation-induced apoptosis via degradation of AKT and MDM2.
    Joo HM; Kim JY; Jeong JB; Seong KM; Nam SY; Yang KH; Kim CS; Kim HS; Jeong M; An S; Jin YW
    Eur J Cell Biol; 2011 May; 90(5):420-31. PubMed ID: 21333377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
    Honda R; Yasuda H
    EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
    Hjerpe R; Aillet F; Lopitz-Otsoa F; Lang V; Torres-Ramos M; Farrás R; Hay RT; Rodríguez MS
    Int J Biochem Cell Biol; 2010 May; 42(5):725-35. PubMed ID: 20080206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac transcription factor Nkx2.5 interacts with p53 and modulates its activity.
    Kojic S; Nestorovic A; Rakicevic L; Protic O; Jasnic-Savovic J; Faulkner G; Radojkovic D
    Arch Biochem Biophys; 2015 Mar; 569():45-53. PubMed ID: 25677450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulatory domain of protein kinase C delta positively regulates insulin receptor signaling.
    Jacob AI; Horovitz-Fried M; Aga-Mizrachi S; Brutman-Barazani T; Okhrimenko H; Zick Y; Brodie C; Sampson SR
    J Mol Endocrinol; 2010 Mar; 44(3):155-69. PubMed ID: 19952103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of a novel p53 down-regulated promoter in intron 3 of the human MDM2 oncogene.
    Liang H; Lunec J
    Gene; 2005 Nov; 361():112-8. PubMed ID: 16202543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
    Ghosh M; Huang K; Berberich SJ
    Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination.
    Ma J; Martin JD; Zhang H; Auger KR; Ho TF; Kirkpatrick RB; Grooms MH; Johanson KO; Tummino PJ; Copeland RA; Lai Z
    Biochemistry; 2006 Aug; 45(30):9238-45. PubMed ID: 16866370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.